Professor Alan Boyd tells his story on The Cat 107.9FM
Following Boyds’ success in the South Cheshire Chamber of Commerce Awards, when the company won Business of the Year (under 25 employees), Professor Alan Boyd has been sharing his career journey, insights into the development of cell and gene therapies for patient benefit, as well as the story behind the growth of Boyds. The radio […]
Horizon 2020 New Deal project for treatment of inflammatory bowel diseases
Boyds has been working with New Deal and a team of European partners on a nanotherapy research project into the treatment of inflammatory bowel diseases. In Europe, over two million people are affected by ulcerative colitis or Crohn’s disease, conditions that are characterised by an inflammation of the bowel (Inflammatory bowel diseases). They occur when cells from […]
Evolution of Ethical Principles in the Practice of Pharmaceutical Medicine From a UK Perspective
Professor Alan Boyd has co-authored a paper which looks at ethical principles in the practice of pharmaceutical medicine, published this month in Frontiers in Pharmacology. The paper, ‘Evolution of Ethical Principles in the Practice of Pharmaceutical Medicine from a UK Perspective’ looks at how pharmaceutical medicine has evolved to be a distinct medical scientific discipline. […]
Boyds scoop Business of the Year at South Cheshire Chamber Awards
Boyds took away the award for Business of the Year (under 25 employees) at the 2019 South Cheshire Chamber of Commerce Business Awards. The annual Awards bring together the South Cheshire business community, showcasing the achievements of a range of businesses and talented individuals. Now in their 23rd year, the Business Awards recognise everything that […]
Boyds Regulatory Team Crowned Winner at 2019 TOPRA Awards
Boyds’ regulatory affairs team won the Futures category at this year’s TOPRA Awards in recognition for its work in cell and gene therapies. The TOPRA Awards for Regulatory Excellence were established in 2010 to reward excellence in regulatory affairs and to recognise the achievement of individuals, teams and organisations both within TOPRA and in the […]
Sabine Ruehle presents at BIA UK Bioscience Forum 2019 – slides now available
Sabine Ruehle, Regulatory Affairs Senior Associate at Boyds, presented at the BIA UK Bioscience Forum 2019 in October at County Hall in Westminster. Sabine’s talk on “Bench to bedside: preclinical considerations for advanced therapies” explored what is needed from the regulatory and safety perspective for the preclinical work to support the administration of ATMPs to […]
Boyds shortlisted as finalist in South Cheshire Chamber Business Awards 2019
Boyds joins the list of finalists for this year’s South Cheshire Chamber of Commerce Business Awards. The Awards bring together the business community in South Cheshire, showcasing the achievements of a range of businesses and talented individuals. Now entering their 23rd year, the Business Awards recognise everything that is great and good about business in […]
Julie Warner awarded TOPRA Distinguished Service Award
Julie Warner, Director of Regulatory Affairs at Boyds, has been awarded the TOPRA Distinguished Service Award. This award recognises volunteers whose contributions have made a real difference to TOPRA and the profession. Julie received the award following a recommendation from one of her peers as well as endorsement from the TOPRA Board. In particular, this […]
Chariots of Fire
Members of the Boyds team in Cambridge and friends, completed the Chariots of Fire run in Cambridge last month. Chariots of Fire is one of Cambridgeshire’s largest annual charity events and took place on the 22 September 2019. Teams of six each run a 1.7 mile course in relay format. The event is organised and […]
Preventing fake medicines from reaching patients
Boyds’ Director of Regulatory Affairs, Julie Warner, has co-edited an article in the October issue of the TOPRA journal, Regulatory Rapporteur, which focuses on falsified medicines. The following article was published in Regulatory Rapporteur, Volume 16, No 10, October 2019. Preventing fake medicines from reaching patients By Julie Warner, Director Regulatory Affairs, Alan Boyd […]
